Cite
HARVARD Citation
Grohe, C. et al. (n.d.). 55PEfficacy and safety of nintedanib and docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First interim results of the ongoing non-interventional study VARGADO (NCT02392455). Annals of oncology. p. . [Online].